Quintiles President of Clinical Development Receives ‘Women in Business’ Award

Triangle Business Journal Honors Quintiles' Paula Brown Stafford as Outstanding Leader in the Raleigh-Durham Community

Paula Brown Stafford, President, Quintiles Clinical Development (Photo: Business Wire)

RESEARCH TRIANGLE PARK, N.C.--()--Quintiles today announced that Paula Brown Stafford, President of Clinical Development, was honored as a recipient of Triangle Business Journal’s Women in Business awards for 2011.

"We are pleased and proud to have Paula recognized as a leading woman in business in the Triangle," said John Ratliff, Quintiles President and Chief Operating Officer. "Paula has made significant contributions to the growth of Quintiles, and her current leadership role is a reflection of her dedication to making a positive difference in healthcare around the world.”

Stafford joined Quintiles in 1985 as a biostatistician and the company’s 23rd employee. Quintiles now employs more than 20,000 people in 60 countries. As President of Clinical Development, Stafford leads a business unit with 15,000 staff globally who are responsible for Phase I-III clinical development services, ranging from clinical monitoring to regulatory submission. In addition to her role at Quintiles, Stafford is the Chair-Elect of the Clinical Data Interchange Standards Consortium (CDISC), and a member of the Foundation Board of the UNC Gillings School of Global Public Health and the UNC-Chapel Hill School of Medicine CTSA External Advisory Board.

The Women in Business awards program recognizes Triangle women who have proven themselves as outstanding leaders with established track records of significant accomplishments in business and community service. This year’s winners were announced at an awards luncheon August 25, 2011 at the Sheraton Imperial in Durham, N.C.

About Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries around the globe works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6842384&lang=en

Contacts

Quintiles
Jay Johnson, Media Relations, 919-998-2091
jay.johnson@quintiles.com
or
Greg Connors, Investor Relations, 919-998-2000
invest@quintiles.com

Contacts

Quintiles
Jay Johnson, Media Relations, 919-998-2091
jay.johnson@quintiles.com
or
Greg Connors, Investor Relations, 919-998-2000
invest@quintiles.com